Modeling Alzheimer’s disease with human multi-omics profiles: Promise to personalized medicine
Current Opinion in Neurobiology · 2026-08 · 99 · 103210
DOI: 10.1016/j.conb.2026.103210 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Neurobiology, 2026-08. Verfasst von Nancy Y Ip. Beteiligte Einrichtung: Division of Life Science, State Key Laboratory of Nervous System Disorders, Daniel and Mayce Yu Molecular Neuroscience Center, The Hong Kong Universi…. Hauptthemen laut MEDLINE: Alzheimer Disease, Multiomics, Precision Medicine, Artificial Intelligence. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Research Grants Council, University Grants Committee, Innovation and Technology Fund, General Research Fund of Shanghai Normal University.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) presents considerable heterogeneity in disease risk and outcomes, posing a major challenge for effective therapeutic development. Recent advances in multi-omics profiling are revolutionizing our understanding of the complex AD pathogenesis. Leveraging long-read sequencing and large-scale multi-ancestry genetic studies, researchers are unraveling the complex polygenic architecture of AD. Additionally, advances in multi-omics techniques unlock the power of molecular profiling of human biological samples, particularly spatial omics of human postmortem brain tissues and molecular profiling of biofluids, to understand the complex AD pathogenesis. Importantly, artificial intelligence (AI)-driven approaches integrate multimodal data to identify molecular features associated with disease risk and endophenotypes, fostering sophisticated models for disease risk predictions and molecular-based patient stratification. Coupled with human-induced pluripotent stem cell-derived brain cell models for validation and mechanistic studies, this comprehensive AI-integrated, multi-omics study approach promises to delineate both shared AD pathological processes and individual variations, paving the way for personalized medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Life Science, State Key Laboratory of Nervous System Disorders, Daniel and Mayce Yu Molecular Neuroscience Center, The Hong Kong University of Science and Technology, Hong Kong Special Administrative Region…
Förderung
- Research Grants Council, University Grants Committee
- Innovation and Technology Fund
- General Research Fund of Shanghai Normal University
- Innovation and Technology Commission
- University Grants Committee
Zitieren
APA
Ip, N. Y. (2026). Modeling Alzheimer’s disease with human multi-omics profiles: Promise to personalized medicine. Current Opinion in Neurobiology, 99, 103210. https://doi.org/10.1016/j.conb.2026.103210
Vancouver
Ip NY. Modeling Alzheimer’s disease with human multi-omics profiles: Promise to personalized medicine. Current Opinion in Neurobiology. 2026;99:103210. doi:10.1016/j.conb.2026.103210
BibTeX
@article{Ip2026,
author = {Ip, Nancy Y},
title = {Modeling Alzheimer’s disease with human multi-omics profiles: Promise to personalized medicine},
journal = {Current Opinion in Neurobiology},
year = {2026},
volume = {99},
pages = {103210},
doi = {10.1016/j.conb.2026.103210}
}
EUVIMED